Author:
Pagliuca Martina,Donato Marco,D’Amato Agostina Lagodin,Rosanova Mario,Russo Anna Orsola Maria,Scafetta Roberta,De Angelis Carmine,Trivedi Meghna V.,André Fabrice,Arpino Grazia,Del Mastro Lucia,De Laurentiis Michelino,Puglisi Fabio,Giuliano Mario
Reference176 articles.
1. A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer - Full Text View - ClinicalTrials.gov (no date). Available at: https://clinicaltrials.gov/ct2/show/NCT03471663?term=NCT03471663&draw=2&rank=1 (Accessed: 18 September 2022).
2. A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With Exemestane Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer) - Full Text View - ClinicalTrials.gov (no date). Available at: https://www.clinicaltrials.gov/ct2/show/NCT05306340 (Accessed: 18 May 2022).
3. A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer - Full Text View - ClinicalTrials.gov (no date). Available at: https://www.clinicaltrials.gov/ct2/show/study/NCT04802759?term=giredestrant&draw=2&rank=8 (Accessed: 9 March 2022).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献